A gold–selenium-bonded nanoprobe for real-timein situimaging of the upstream and downstream relationship between uPA and MMP-9 in cancer cells
- 23 April 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 55 (41) , 5817-5820
Abstract
A novel Au–Se nanoprobe with remarkable anti-interference ability for glutathione was developed for real-time in situ monitoring of the upstream and downstream regulatory relationship between uPA and MMP-9 proteins in the pathway.Keywords
Funding Information
- National Natural Science Foundation of China (21390411, 21505087, 21535004, 21775094, 21874086, 91753111)
This publication has 36 references indexed in Scilit:
- Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanismNature Communications, 2018
- Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesotheliomaOncotarget, 2016
- cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancerOncotarget, 2016
- Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: Involvement of PI3K/Akt and MAPK signaling pathwaysPharmacological Research, 2012
- Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY‐142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell linesInternational Journal of Cancer, 2009
- Targeting PI3K signalling in cancer: opportunities, challenges and limitationsNature Reviews Cancer, 2009
- PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant CancersCancer Research, 2009
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumorsOncogene, 1999